INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Operating cash flow 2016–2025
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$50.4MFY2025 · since FY2016: $116.4M → $50.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $50.4M | -61.1% |
| FY2024 | $129.4M | -7.6% |
| FY2023 | $140.0M | -47.1% |
| FY2022 | $264.5M | -15.4% |
| FY2021 | $312.4M | +53.3% |
| FY2020 | $203.8M | -11.9% |
| FY2019 | $231.4M | +15.9% |
| FY2018 | $199.7M | +74.3% |
| FY2017 | $114.5M | -1.6% |
| FY2016 | $116.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IART financial trends
IART RevenueIART Net incomeIART Net marginIART Gross profitIART Gross marginIART Operating incomeIART Operating marginIART Free cash flowIART Capital expendituresIART Return on equityIART Stock buybacksIART Dividends paidIART Total assetsIART Total liabilitiesIART Shareholders’ equityIART overview →